Adage Capital Partners’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Adage Capital Partners’s Portfolio RVMDW Stock Details RVMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$895K	Hold	500,000	–	–	﹤0.01%	871
2025 Q4	$470K	Hold	500,000	–	–	﹤0.01%	863
2025 Q3	$150K	Hold	500,000	–	–	﹤0.01%	860
2025 Q2	$131K	Hold	500,000	–	–	﹤0.01%	833
2025 Q1	$19K	Hold	500,000	–	–	﹤0.01%	832
2024 Q4	$90K	Hold	500,000	–	–	﹤0.01%	854
2024 Q3	$70K	Hold	500,000	–	–	﹤0.01%	836
2024 Q2	$51K	Hold	500,000	–	–	﹤0.01%	828
2024 Q1	$91.3K	Hold	500,000	–	–	﹤0.01%	828
2023 Q4	$165K	Buy	+500,000	New	+$223K	﹤0.01%	793

Other funds holding RVMDW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Adage Capital Partners's RVMDW Position: Q1 2026 in Review

Adage Capital Partners held its Revolution Medicines Inc Warrant (RVMDW) position steady in Q1 2026 at 500,000 shares worth $895K. The position accounts for ﹤0.01% of the portfolio, ranked #871.

Adage Capital Partners first reported a position in RVMDW in Q4 2023 and has held it in 10 quarters since. 23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

Adage Capital Partners held 500,000 shares of Revolution Medicines Inc Warrant worth $895K as of Q1 2026.
Adage Capital Partners left its Revolution Medicines Inc Warrant share count unchanged in Q1 2026.
Revolution Medicines Inc Warrant made up ﹤0.01% of Adage Capital Partners's portfolio in Q1 2026, its #871 holding.
Adage Capital Partners first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 10 quarters since.
23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.